{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T22:10:55Z","timestamp":1790892655356,"version":"4.1.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,2,16]],"date-time":"2022-02-16T00:00:00Z","timestamp":1644969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,2,16]],"date-time":"2022-02-16T00:00:00Z","timestamp":1644969600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004914","name":"Ferring Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004914","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Central diabetes insipidus (CDI) is a rare condition, with significant impact on patient health and well-being. It is a chronic condition which usually requires meticulous long-term care. It can affect both children and adults. There is limited literature considering the needs and challenges inherent in providing high quality care to patients with CDI, across the care pathway. This paper seeks to address this gap by providing a unique and well-rounded understanding of clinical and healthcare systems-related challenges. It draws on insights from the literature, from direct clinical experience contributed by five clinicians as co-authors (providing insights from France, Ireland, Italy, Spain and the United Kingdom), and from patient perspectives provided through interviews with patient representatives from three patient organisations. We identify clinical challenges related to the diagnosis of CDI, including differentiating between other similar conditions and determining the underlying aetiology. Treatment is challenging, given the need to tailor medication to each patient\u2019s needs and ongoing management is required to ensure that patients continue to respond adequately to treatment. Ongoing support is required when patients switch between formulations. We also identify healthcare systems challenges related to limited awareness of CDI amongst primary care physicians and general paediatricians, and the need for highly skilled specialist care and appropriate workforce capacity. There is also a significant need for raising awareness and for the education of both healthcare professionals and patients about different aspects of CDI, with the aim of supporting improved care and effective patient engagement with healthcare professionals. We reflect on this information and highlight improvement opportunities. These relate to developing guidance to support patients, carers, primary care physicians and general paediatricians to identify clinical features earlier, and to consider CDI as a possible diagnosis when a patient presents with suggestive symptoms.<\/jats:p>","DOI":"10.1186\/s13023-022-02191-2","type":"journal-article","created":{"date-parts":[[2022,2,16]],"date-time":"2022-02-16T11:03:06Z","timestamp":1645009386000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Challenges and improvement needs in the care of patients with central diabetes insipidus"],"prefix":"10.1186","volume":"17","author":[{"given":"H.","family":"Teare","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Argente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Dattani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Leger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Maghnie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Sherlock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.-C.","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Francombe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6956-2007","authenticated-orcid":false,"given":"S.","family":"Marjanovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,2,16]]},"reference":[{"issue":"2","key":"2191_CR1","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.beem.2016.02.005","volume":"30","author":"S Ananthakrishnan","year":"2016","unstructured":"Ananthakrishnan S. Diabetes insipidus during pregnancy. Best Pract Res Clin Endocrinol Metab. 2016;30(2):305\u201315.","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"9","key":"2191_CR2","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1507\/endocrj.EJ13-0165","volume":"60","author":"H Arima","year":"2013","unstructured":"Arima H, Oiso Y, Juul KV, N\u00f8rgaard JP. Efficacy and safety of desmopressin orally disintegrating tablet in patients with central diabetes insipidus: results of a multicenter open-label dose-titration study. Endocr J. 2013;60(9):1085\u201394.","journal-title":"Endocr J"},{"issue":"4","key":"2191_CR3","doi-asserted-by":"publisher","first-page":"61","DOI":"10.17116\/neiro201781461-69","volume":"81","author":"LI Astaf'eva","year":"2017","unstructured":"Astaf\u2019eva LI. The efficacy of desmopressin in the treatment of central diabetes insipidus after resection of chiasmo-sellar region tumors. Zh Vopr Neirokhir Im N Burdenko. 2017;81(4):61\u20139.","journal-title":"Zh Vopr Neirokhir Im N Burdenko"},{"issue":"7","key":"2191_CR4","doi-asserted-by":"publisher","first-page":"G8","DOI":"10.1530\/EC-18-0154","volume":"7","author":"SE Baldeweg","year":"2018","unstructured":"Baldeweg SE, Ball S, Brooke A, Gleeson HK, Levy MJ, Prentice M, et al. Society for endocrinology clinical guidance: Inpatient management of cranial diabetes insipidus. Endocr Connect. 2018;7(7):G8-g11.","journal-title":"Endocr Connect"},{"issue":"1","key":"2191_CR5","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1007\/s11102-017-0846-2","volume":"21","author":"M Barbot","year":"2018","unstructured":"Barbot M, Ceccato F, Zilio M, Albiger N, Sigon R, Rolma G, et al. Cardiovascular autonomic dysfunction in patients with idiopathic diabetes insipidus. Pituitary. 2018;21(1):50\u20135.","journal-title":"Pituitary"},{"issue":"2","key":"2191_CR6","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.ando.2016.04.005","volume":"77","author":"P Chanson","year":"2016","unstructured":"Chanson P, Salenave S. Diabetes insipidus and pregnancy. Ann Endocrinol (Paris). 2016;77(2):135\u20138.","journal-title":"Ann Endocrinol (Paris)"},{"issue":"1","key":"2191_CR7","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1038\/s41572-019-0103-2","volume":"5","author":"M Christ-Crain","year":"2019","unstructured":"Christ-Crain M, Bichet DG, Fenske WK, Goldman MB, Rittig S, Verbalis JG, et al. Diabetes insipidus. Nat Rev Dis Primers. 2019;5(1):54.","journal-title":"Nat Rev Dis Primers"},{"issue":"1","key":"2191_CR8","doi-asserted-by":"publisher","first-page":"G9","DOI":"10.1530\/EJE-20-0338","volume":"183","author":"M Christ-Crain","year":"2020","unstructured":"Christ-Crain M, Hoorn EJ, Sherlock M, Thompson CJ, Wass JAH. Endocrinology in the time of COVID-19: management of diabetes insipidus and hyponatremia. Eur J Endocrinol. 2020;183(1):G9-g15.","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"2191_CR9","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.beem.2016.02.006","volume":"30","author":"E Dabrowski","year":"2016","unstructured":"Dabrowski E, Kadakia R, Zimmerman D. Diabetes insipidus in infants and children. Best Pract Res Clin Endocrinol Metab. 2016;30(2):317\u201328.","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"2191_CR10","doi-asserted-by":"crossref","unstructured":"Elder C, Dimitri P. Diabetes insipidus and the use of desmopressin in hospitalised children. Arch Dis Childh Educ Pract Ed 2017;102:edpract-2016.","DOI":"10.1136\/archdischild-2016-310763"},{"issue":"1","key":"2191_CR11","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1111\/cen.13866","volume":"90","author":"A Garrahy","year":"2019","unstructured":"Garrahy A, Moran C, Thompson CJ. Diagnosis and management of central diabetes insipidus in adults. Clin Endocrinol (Oxf). 2019;90(1):23\u201330.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2191_CR12","doi-asserted-by":"crossref","unstructured":"Garrahy A, Thompson CJ. Management of central diabetes insipidus. Best Pract Res Clin Endocrinol Metab. 2020:101385.","DOI":"10.1016\/j.beem.2020.101385"},{"key":"2191_CR13","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s13633-016-0021-y","volume":"2016","author":"JD Hunter","year":"2016","unstructured":"Hunter JD, Calikoglu AS. Etiological and clinical characteristics of central diabetes insipidus in children: a single center experience. Int J Pediatr Endocrinol. 2016;2016:3.","journal-title":"Int J Pediatr Endocrinol"},{"issue":"1","key":"2191_CR14","first-page":"85","volume":"44","author":"A Ito","year":"2019","unstructured":"Ito A, Nozaki A, Horie I, Ando T, Kawakami A. Relation between change in treatment for central diabetes insipidus and body weight loss. Minerva Endocrinol. 2019;44(1):85\u201390.","journal-title":"Minerva Endocrinol"},{"issue":"1","key":"2191_CR15","doi-asserted-by":"publisher","first-page":"9","DOI":"10.4103\/2230-8210.172273","volume":"20","author":"S Kalra","year":"2016","unstructured":"Kalra S, Zargar AH, Jain SM, Sethi B, Chowdhury S, Singh AK, et al. Diabetes insipidus: the other diabetes. Indian J Endocrinol Metab. 2016;20(1):9\u201321.","journal-title":"Indian J Endocrinol Metab"},{"issue":"2","key":"2191_CR16","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1507\/endocrj.EJ14-0368","volume":"62","author":"Y Kataoka","year":"2015","unstructured":"Kataoka Y, Nishida S, Hirakawa A, Oiso Y, Arima H. Comparison of incidence of hyponatremia between intranasal and oral desmopressin in patients with central diabetes insipidus. Endocr J. 2015;62(2):195\u2013200.","journal-title":"Endocr J"},{"issue":"5","key":"2191_CR17","doi-asserted-by":"publisher","first-page":"600","DOI":"10.4158\/EP161555.OR","volume":"23","author":"H Masri-Iraqi","year":"2017","unstructured":"Masri-Iraqi H, Hirsch D, Herzberg D, Lifshitz A, Tsvetov G, Benbassat C, et al. Central diabetes insipidus: clinical characteristics and long-term course in a large cohort of adults. Endocr Pract. 2017;23(5):600\u20134.","journal-title":"Endocr Pract"},{"issue":"6","key":"2191_CR18","first-page":"623","volume":"30","author":"M Mavinkurve","year":"2017","unstructured":"Mavinkurve M, McGrath N, Johnston N, Moloney S, Murphy NP, Hawkes CP. Oral administration of diluted nasal desmopressin in managing neonatal central diabetes insipidus. J Pediatr Endocrinol Metab. 2017;30(6):623\u20138.","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"1","key":"2191_CR19","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1007\/s12020-015-0637-3","volume":"51","author":"A Nozaki","year":"2016","unstructured":"Nozaki A, Ando T, Akazawa S, Satoh T, Sagara I, Horie I, et al. Quality of life in the patients with central diabetes insipidus assessed by Nagasaki Diabetes Insipidus Questionnaire. Endocrine. 2016;51(1):140\u20137.","journal-title":"Endocrine"},{"key":"2191_CR20","doi-asserted-by":"crossref","unstructured":"Patti G, Ibba A, Morana G, Napoli F, Fava D, di Iorgi N, et al. Central diabetes insipidus in children: Diagnosis and management. Best Pract Res Clin Endocrinol Metab. 2020:101440.","DOI":"10.1016\/j.beem.2020.101440"},{"issue":"3","key":"2191_CR21","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1530\/EJE-19-0299","volume":"181","author":"G Patti","year":"2019","unstructured":"Patti G, Scianguetta S, Roberti D, Di Mascio A, Balsamo A, Brugnara M, et al. Familial neurohypophyseal diabetes insipidus in 13 kindreds and 2 novel mutations in the vasopressin gene. Eur J Endocrinol. 2019;181(3):233\u201344.","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"2191_CR22","doi-asserted-by":"publisher","first-page":"458","DOI":"10.23736\/S0391-1977.18.02807-9","volume":"43","author":"J Refardt","year":"2018","unstructured":"Refardt J, Christ-Crain M. Diabetes insipidus in pregnancy: how to advice the patient? Minerva Endocrinol. 2018;43(4):458\u201364.","journal-title":"Minerva Endocrinol"},{"issue":"3","key":"2191_CR23","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.ecl.2020.05.012","volume":"49","author":"J Refardt","year":"2020","unstructured":"Refardt J, Winzeler B, Christ-Crain M. Diabetes Insipidus: An Update. Endocrinol Metab Clin North Am. 2020;49(3):517\u201331.","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"4","key":"2191_CR24","doi-asserted-by":"publisher","first-page":"R155","DOI":"10.1530\/EJE-19-0298","volume":"181","author":"E Sbardella","year":"2019","unstructured":"Sbardella E, Pozza C, Isidori AM, Grossman AB. Endocrinology and adolescence: dealing with transition in young patients with pituitary disorders. Eur J Endocrinol. 2019;181(4):R155\u201371.","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"2191_CR25","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.1210\/jc.2016-1157","volume":"101","author":"AR Smego","year":"2016","unstructured":"Smego AR, Backeljauw P, Gutmark-Little I. Buccally administered intranasal desmopressin acetate for the treatment of neurogenic diabetes insipidus in infancy. J Clin Endocrinol Metab. 2016;101(5):2084\u20138.","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-022-02191-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-022-02191-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-022-02191-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,16]],"date-time":"2022-02-16T11:08:57Z","timestamp":1645009737000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-022-02191-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,16]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["2191"],"URL":"https:\/\/doi.org\/10.1186\/s13023-022-02191-2","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,16]]},"assertion":[{"value":"26 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This research took the form of a literature review, supplemented with a small number of interviews and workshops with clinical experts and representatives from patient organisations. It was judged to pose minimal risks to participants and ethical approval was not sought. The research was conducted in accordance with the Declaration of Helsinki. All participants gave informed consent and were provided with participant information sheets as part of this process.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have consented to the publication of this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no competing interests to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"58"}}